-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
March 01, 2013 - None of the investigators has any affiliations or financial involvement that conflicts with the
material
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2021-Compendium-TechDoc-rev.pdf
January 01, 2021 - limited
version;
through
data use
agreement
for the full
version
IRS 990
and
Schedule
R
IRS Financial
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2020-Compendium-TechDoc-rev.pdf
January 01, 2020 - limited
version;
through
data use
agreement
for the full
version
IRS 990
and
Schedule
R
IRS Financial
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2018-Compendium-TechDoc-update.pdf
January 01, 2018 - limited
version;
through
data use
agreement
for the full
version
IRS 990
and
Schedule
R
IRS Financial
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
January 01, 2010 - 1
Comparative Effectiveness Review
Number 111
Allergen-Specific Immunotherapy for the Treatment
of Allergic Rhinoconjunctivitis and/or Asthma:
Comparative Effectiveness Review
Executive Summary
Background
Allergic rhinitis is a widespread
clinical problem, estimated to affect
20 to 40 percent of the popu…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/sepsis-1.pdf
March 01, 2020 - Chapter-3 - Sepsis Recognition
Sepsis Recognition 3-1
3. Sepsis Recognition
Authors: Bryan Gale, M.A., and Kendall K. Hall, M.D., M.S.
Introduction
Sepsis has been a leading cause of hospitalization and death in U.S. healthcare settings for many years,
and accounts for more hospital admissions and spending than…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TYPA75a_t7HaJeDhWqCJ9n
August 13, 2019 - The USPSTF members, external
reviewers, and federal partner reviewers did not
receive financial compensation